Otros idiomas Profound Medical Corp.

Acciones

PRN

CA74319B5027

Diferido Toronto S.E. Otros sitios de cotización 18:16:17 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
10,36 ^CAD	+2,98 %		-1,33 %	-6,67 %

13/03	Transcript : Profound Medical Corp. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
11/03	PROFOUND MEDICAL CORP. : Alliance Global Partners mantiene su recomendación de compra	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow	22/04
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
Profound Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Profound Medical Reports Q4 Net Loss of US$0.42 Per Share, Announces COO Appointment	07/03
Profound Medical Brief: Announcing promotion of Mathieu Burtnyk, from SVP Product Leader to Chief Operating Officer	07/03
Profound Medical Brief: Q4 2023 net loss was approximately US$8.9 million, or $0.42 per common share	07/03
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results	07/03
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms	07/03
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference	04/03
Profound Medical Collaborates With Siemens Healthineers to Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical Corp. Enters into A Non-Exclusive Collaboration with Siemens Healthineers	27/02
Profound Medical Brief: Entering Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure	27/02
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow	15/02
Profound Medical Up 1.9% In US After Hours As Announces Non-Brokered Private Placement	16/01
Profound Medical Announces Non-Brokered Private Placement	16/01
Profound Medical Corp. announced that it expects to receive $2.937503 million in funding	16/01
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)	04/01
Profound Medical Brief: Adds Top priorities for 2024 will be to further increase Its TULSA-PRO installed base, support increased system utilization, complete its ongoing Level 1 CAPTAIN trial	03/01
Profound Medical Brief: For Full year 2023, Anticipates total revenues to be in Approximate range of US$7.1 million to $7.2 million	03/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Profound Medical Corp.

Acciones

PRN

CA74319B5027

Otros idiomas

Filtros